Open access · US-GOV via ClinicalTrials.gov Clinical trial

Significantly Reduced Median Effective Dose (ED50) of Remimazolam for Anesthesia Induction in Frail Elderly Patients: A Prospective Dose-Finding Clinical Trial With Respiratory Volume Monitoring

Authors not listed

The First Hospital of Hebei Medical University · 2025

Dysbiosis Human Randomized controlled trial

Abstract

This study aimed to determine the median effective dose (ED50) of remimazolam for loss of consciousness (LOC) in elderly and frail elderly patients using the Dixon up-and-down method, while utilizing a novel Respiratory Volume Monitor (RVM) to detect subclinical respiratory depression.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-12 MST

Cite this

APA

Anonymous. (2025). Significantly Reduced Median Effective Dose (ED50) of Remimazolam for Anesthesia Induction in Frail Elderly Patients: A Prospective Dose-Finding Clinical Trial With Respiratory Volume Monitoring. <em>The First Hospital of Hebei Medical University</em>. https://clinicaltrials.gov/study/NCT07467603

Vancouver

Anonymous. Significantly Reduced Median Effective Dose (ED50) of Remimazolam for Anesthesia Induction in Frail Elderly Patients: A Prospective Dose-Finding Clinical Trial With Respiratory Volume Monitoring. The First Hospital of Hebei Medical University. 2025.

BibTeX

@misc{anon2025Signif, title = {Significantly Reduced Median Effective Dose (ED50) of Remimazolam for Anesthesia Induction in Frail Elderly Patients: A Prospective Dose-Finding Clinical Trial With Respiratory Volume Monitoring}, author = {Anonymous}, journal = {The First Hospital of Hebei Medical University}, year = {2025}, }